Skip to main content
Log in

Estimating cost effectiveness of hepatitis B vaccination in US adults

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2020 US dollars

Reference

  • Janssen RS, et al. Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination. Vaccine : 14 Aug 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2021.07.100

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Estimating cost effectiveness of hepatitis B vaccination in US adults. PharmacoEcon Outcomes News 886, 11 (2021). https://doi.org/10.1007/s40274-021-07989-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-07989-7

Navigation